Yaling Hu

InstitutionSinovac Biotech Co.
AddressBeijing
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in March 2021
    All Publications
    Bar chart showing 17 publications over 8 distinct years, with a maximum of 6 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zhao Y, Kuang M, Li J, Zhu L, Jia Z, Guo X, Hu Y, Kong J, Yin H, Wang X, You F. Publisher Correction: SARS-CoV-2 spike protein interacts with and activates TLR4. Cell Res. 2021 Jul; 31(7):825. PMID: 33907310.
      Citations: 5     Fields:    
    2. Guan L, Yu Y, Wu X, Nie J, Zhang J, Wang Z, Li N, Shi R, Zhao H, Chen H, Luo C, Hu Y, Wang Y, Huang W, Xu M, Hou J. The first Chinese national standards for SARS-CoV-2 neutralizing antibody. Vaccine. 2021 06 23; 39(28):3724-3730. PMID: 34059373.
      Citations: 1     Fields:    Translation:Humans
    3. Zhao Y, Kuang M, Li J, Zhu L, Jia Z, Guo X, Hu Y, Kong J, Yin H, Wang X, You F. SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res. 2021 07; 31(7):818-820. PMID: 33742149.
      Citations: 26     Fields:    Translation:HumansCells
    4. Feng X, Yin J, Zhang J, Hu Y, Ouyang Y, Qiao S, Zhao H, Zhang T, Li X, Zhang L, Zhang J, Jin R, Feng Y, Su B. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China. Front Immunol. 2021; 12:614436. PMID: 33790892.
      Citations: 5     Fields:    Translation:HumansCells
    5. Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, Li M, Jin H, Cui G, Chen P, Wang L, Zhao G, Ding Y, Zhao Y, Yin W. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 06; 21(6):803-812. PMID: 33548194.
      Citations: 94     Fields:    Translation:HumansPHPublic Health
    6. Shen Y, Ba Y, Hu Y, Wang L, Li W. Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge. Inflamm Res. 2021 Feb; 70(2):241-247. PMID: 33385239.
      Citations: 1     Fields:    Translation:HumansCells
    7. Wang X, Guo X, Xin Q, Pan Y, Hu Y, Li J, Chu Y, Feng Y, Wang Q. Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients. Clin Infect Dis. 2020 12 17; 71(10):2688-2694. PMID: 32497196.
      Citations: 107     Fields:    Translation:Humans
    8. Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 02; 21(2):181-192. PMID: 33217362.
      Citations: 278     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    9. Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, Gao H, Ge X, Kan B, Hu Y, Liu J, Cai F, Jiang D, Yin Y, Qin C, Li J, Gong X, Lou X, Shi W, Wu D, Zhang H, Zhu L, Deng W, Li Y, Lu J, Li C, Wang X, Yin W, Zhang Y, Qin C. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020 07 03; 369(6499):77-81. PMID: 32376603.
      Citations: 457     Fields:    Translation:AnimalsCellsPHPublic Health